Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Fast Track Drug Development Programs Designation, Development, and Application Review

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled ``Guidance for Industry: Fast Track Drug Development Programs--Designation, Development, and Application Review'' has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.